Variations in treatment patterns for metastatic renal cell carcinoma (mRCC) between developing and developed countries
Variations in treatment patterns for metastatic renal cell carcinoma (mRCC) between developing and...
Read More
Kidney Cancer Journal
Validation of the Preoperative Nomogram Predicting 12-Year Probability of Metastatic Renal Cancer
Validation of the Preoperative Nomogram Predicting 12-Year Probability of Metastatic Renal Cancer...
Read More
Updated Results From a Phase I Study of Nivolumab in Combination With Sunitinib or Pazopanib in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
Updated Results From a Phase I Study of Nivolumab in Combination With Sunitinib or Pazopanib in...
Read More
Updated Results From a Phase I Study of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
Updated Results From a Phase I Study of Nivolumab in Combination With Ipilimumab in Metastatic...
Read More
Treatment patterns among patients with metastatic renal cell carcinoma receiving systemic therapies in US real-world settings between 2006 and 2017
Treatment patterns among patients with metastatic renal cell carcinoma receiving systemic...
Read MoreExercise & Wellness
Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan